EN ▾
SNAPE REP RT Front page →
UnconfirmedScience & maths18 Nov, 12:00 UTC

Boltz raises $110M Series A as usage of its AI drug design software jumps 50-fold

Boltz co-founders Jeremy Wohlwend, Gabriele Corso and Saro Passaro
Endpoints News

Less than a year after leaving stealth with $28M, the open-model biomolecular design startup told Endpoints News of the round; an October SEC Form D had shown about $97.4M sold.

Read at Endpoints News Share

Sources

More on Science & maths
More from Snape ReportFront page →